Context Therapeutics Inc (CNTX)
2.005
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Accounts Payable (Quarterly): 2.045M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.045M |
December 31, 2023 | 2.383M |
September 30, 2023 | 1.828M |
June 30, 2023 | 1.191M |
March 31, 2023 | 1.210M |
December 31, 2022 | 0.9363M |
September 30, 2022 | 1.495M |
Date | Value |
---|---|
June 30, 2022 | 0.9455M |
March 31, 2022 | 0.4548M |
December 31, 2021 | 1.826M |
September 30, 2021 | 3.083M |
June 30, 2021 | 1.719M |
March 31, 2021 | 1.888M |
December 31, 2020 | 2.708M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.4548M
Minimum
Mar 2022
3.083M
Maximum
Sep 2021
1.694M
Average
1.773M
Median
Accounts Payable (Quarterly) Benchmarks
Emergent BioSolutions Inc | 100.20M |
AbbVie Inc | -- |
Revance Therapeutics Inc | 5.276M |
Design Therapeutics Inc | 1.372M |
NovaBay Pharmaceuticals Inc | 1.117M |